Background Image
Table of Contents Table of Contents
Previous Page  10 / 78 Next Page
Information
Show Menu
Previous Page 10 / 78 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 4, July/August 2015

156

AFRICA

One hundred and thirty-eight of the patients were male, and the

mean age was 62.7

±

9.9 years. The demographic characteristics

of the patients are summarised in Table 1.

All of the patients were operated on with standard

cardiopulmonary bypass under general anaesthesia. Antegrade

cardioplegia was used for cardiac protection. In all cases, an

IABP catheter was inserted through the common femoral artery.

In this study, IABP was used intra-operatively when weaning

from cardiopulmonary bypass had failed. Pre-operative IABP

was used in cases of low cardiac output, unstable refractory

angina, or persistent arrhythmia due to myocardial ischaemia.

5,10

The patients were classified according to age; whether they

were younger than 65 years or older. The mortality rate,

complications of IABP, intra-operative properties, pre-operative

clinical characteristics of patients, and length of stay in the

intensive care unit were recorded.

The pre-operative parameters of the patients were age,

gender, re-operation, hypertension, body mass index, diabetes

mellitus, chronic renal failure, EuroSCORE value, previous

cerebrovascular accident, left ventricular ejection fraction, left

main coronary artery disease, chronic obstructive pulmonary

disease (COPD), and the presence of a myocardial infarction

more recent than one week earlier. The pre-operative clinical

characteristics, postoperative complications, duration of ICU and

hospital stays, and mortality rates of the groups were compared.

Statistical analysis

Demographic characteristics were compared with mean and

median values. Parametric results were evaluated using a

Student’s

t

-test and Tukey test. A chi-square method, Pearson’s

test, and Fisher’s test were used to analyse the categorical

parameters. Risk factors for mortality were assessed using a

binary logistic regression analysis. The standard deviation value

p

<

0.05 was considered significant. SPSS 18 was used for the

statistical analysis.

Results

In this study, 138 of the 190 patients were male. The mean patient

age was 62.7

±

9.9 years. Ninety-eight patients were younger than

65 years of age, and 90 patients were 65 years of age or older.

The number of patients with chronic obstructive pulmonary

disease and the mean EuroSCORE value of the patients were

higher in the older group. By contrast, the number of patients

with diabetes mellitus was higher in the younger group. In terms

of other demographic characteristics, there were no statistically

significant differences between the groups (Table 1). The mean

cardiopulmonary bypass times, mean cross-clamp times, and

number of grafts used were similar between the two groups

(Table 2).

Fifty-seven (30.1%) patients died in the first 30 days following

the operation. Twenty-three of these patients were in the younger

group. The mortality rate of the younger group was significantly

Table 1. Demographic characteristics of the patients

Younger

group

(n

=

98)

Older

group

(n

=

92) Total

p-value

Male/female

74/24

64/28 138/52 0.358

Mean age

54.7

±

6.1 71.4

±

4.5 62.7

±

9.9

<

0.001

Mean EF

37.1

±

8.3 39.2

±

9.5 38.1

±

8.9 0.121

MI,

n

(%)

31 (31.9) 24 (26) 55 (27.7)

0.400

COPD,

n

(%)

5 (5.1) 13 (14.1)

18 (9)

0.034

CRF,

n

(%)

3 (3)

5 (5.4)

8 (4.2)

0.487

Redo,

n

(%)

3 (3)

0

3 (1.5)

0.297

HT,

n

(%)

47 (48)

56 (60) 103 (54)

0.074

DM,

n

(%)

48 (49)

23 (25) 71 (37.3)

0.001

CVA,

n

(%)

4 (4.1)

5 (5.4)

9 (4.7)

0.745

Recent MI,

n

(%)

18 (18.3) 16 (17.4) 34 (17.9)

0.861

EuroSCORE

4 (0–10) 5 (2–10) 4 (0–10)

<

0.001

BMI

27.2

±

4 26.7

±

4.4 27.2

±

4.1 0.112

LMCA

8 (8.1)

5 (5.4)

13 (6.8)

0.457

Prophylactic levosimendan 18 (18.3) 12 (13) 30 (15.8)

0.315

Emergency

18 (18.3) 16 (17.4) 34 (17.8)

0.861

Pre-operative IABP

8 (8.1)

9 (9.7)

17

0.405

COPD: chronic obstructive pulmonary disease, CRF: chronic renal

failure, HT: hypertension, DM: diabetes mellitus, CVA: cerebrovas-

cular accident, MI: myocardial infarction, BMI: body mass index,

LMCA: left main coronary artery disease, EF: ejection fraction.

Table 2. Mortality rates and clinical outcomes of the patients

Younger group

(n

=

98)

Older group

(n

=

92)

p-value

Mortality

23 (23.4)

34 (36.9)

0.043

Mortality*

8 (44.4)

7 (41.1 %)

0.964

Mortality**

15 (18.7)

27 (36%)

0.018

CPB time (min)

143

±

59

140

±

58

0.786

Graft number

3.1 (2–5)

3.2 (2–5)

0.789

Cross clamp time (min)

90

±

34

88

±

38

0.604

ICU time (days)

5.9

±

4

6.6

±

5

0.284

ICU: intensive care unit, CPB time: cardiopulmonary bypass time,

*patients undergoing emergency operations, **patients undergoing

elective operations.

Table 3. Risk factors in patients who survived or died

Patients survived

(n

=

133)

Patients died

(n

=

57) p-value

Pre-operative MI,

n

(%)

40 (30)

15 (26.3)

0.601

BMI

27.5

±

4.2

26.9

±

4

0.507

EuroSCORE

4.2 (0-10)

5.1 (0-10)

0.030

DM,

n

(%)

47 (35.3)

24 (42.1)

0.377

CRF,

n

(%)

3 (2.2)

5 (8.7)

0.040

Mean EF %

38.4

±

8

37.5

±

9

0.562

Mean age (year)

61.8

±

9.8

64.9

±

10

0.051

Older patients,

n

(%)

58 (43.6)

34 (59.6)

0.043

Gender (female/male)

33/101

20/37

0.118

COPD,

n

(%)

12 (9)

6 (10.5)

0.746

Emergency operation,

n

(%)

19 (14.2)

15 (26.3)

0.047

LMCA,

n

(%)

8 (6)

5 (8.7)

0.490

CVA,

n

(%)

5 (3.7)

4 (7)

0.333

HT,

n

(%)

69 (51.8)

34 (59.6)

0.328

Re-operation,

n

(%)

3 (2.2)

0

0.555

Pre-operative IABP,

n

(%)

14 (10.5)

3 (2.2)

0.405

CPB time (min)

130

±

48

167

±

72

<

0.001

Cross-clamp time (min)

87

±

35

94

±

36

0.180

CPB time: cardiopulmonary bypass time. COPD: chronic obstructive

pulmonary disease. CRF: chronic renal failure. HT: hypertension.

DM: diabetes mellitus. CVA: previous cerebrovascular accident. BMI:

body mass index. LMCA: left main coronary artery disease.